Breast Cancer News and Research

Latest Breast Cancer News and Research

Immunotherapy could help some breast cancer patients based on genetic changes in their tumors

Immunotherapy drugs could help some breast cancer patients based on the genetic changes in their tumors, researchers at the Wellcome Trust Sanger Institute and their collaborators find.

13 Sep 2017

MTI awards $25,000 grant to MDI Biological Laboratory scientist for peripheral neuropathy research

The Maine Technology Institute has awarded a $25,000 seed grant to Sandra Rieger, Ph.D., of the MDI Biological Laboratory to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet and affects an estimated 20 to 40 million Americans.

13 Sep 2017

Study finds potential preventive for chemotherapy-induced peripheral neuropathy

Chemotherapy-induced peripheral neuropathy, or CIPN, is a common side effect of cancer treatment that causes shooting or burning pain, numbness, tingling and cold sensitivity of the hands and feet for many cancer patients.

13 Sep 2017

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

An International Journal of Cancer study found that female survivors of certain types of cancer have higher risks of poor outcomes in pregnancies conceived after diagnosis than women without cancer.

12 Sep 2017

Researchers reveal possible origin of cancer-associated fibroblasts

Researchers at Okayama University describe in Scientific Reports that cancer-associated fibroblasts — cells that play a key role in cancer progression — originate from cancer stem cells. Preventing cancer stem cells from transforming into cancer-associated fibroblast may be a promising approach towards cancer treatment.

12 Sep 2017

Study identifies late effects that may interfere with work status of young adult cancer survivors

Factors that limit the work ability of young adult cancer survivors are reported today at the ESMO 2017 Congress in Madrid.

11 Sep 2017

LORELEI trial: Treatment with alpha specific PI3K inhibitor reduces breast tumor size

Adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer that was both estrogen receptor positive and HER2-negative (ER+/HER2-) according to results of the LORELEI trial, presented at the ESMO 2017 Congress in Madrid.

8 Sep 2017

Research: Alcohol industry misrepresenting evidence about alcohol-related cancer risk

The alcohol industry is misrepresenting evidence about the alcohol-related risk of cancer with activities that have parallels with those of the tobacco industry, according to new research published in the journal Drug and Alcohol Review.

8 Sep 2017

Eli Lilly to lay off 8.5 percent of employees in bid to cut costs

Eli Lilly and Company announced yesterday that they have decided to lay off around 8.5 percent of their employees. The company was on its way to develop two potential major drugs over the past year but set backs have led to major financial losses, leading to this decision.

7 Sep 2017

Alcohol related cancer risks underplayed by industry says new research

A report out of the UK reveals that just like the tobacco industry tried for decades to suppress the harmful effects of tobacco and cigarette smoking, the alcohol industry too is trying to underplay the actual cancer risks associated with alcohol intake. The new research is published in the journal Drug and Alcohol Review.

7 Sep 2017

Seeing the full picture, real-time analysis of live-cells

Every cell is a miniature factory taking in raw material (extracellular signals) and processing it to produce something (a biological response). But unlike a factory that can be easily tweaked to run at steady-state and look the same from day to day, cells are dynamic.

From Sartorius 7 Sep 2017

New microfluidic device offers insights on cancer metastasis

As cancer grows, it evolves. Individual cells become more aggressive and break away to flow through the body and spread to distant areas.

7 Sep 2017

Myriad Genetics introduces new precision medicine tool to enhance myRisk Hereditary Cancer test

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore, a new clinically validated precision medicine tool to enhance its myRisk Hereditary Cancer test. riskScore quantifies a woman's risk of developing breast cancer by combining genetic markers throughout the genome with her family and clinical history.

7 Sep 2017

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

For many years, oncologists have known that cancers can secrete complex molecules into the blood and that levels of these molecules can be easily measured. These so-called 'tumor markers' are traditionally associated with a single dominant cancer type, for example Prostate Specific Antigen (PSA) linked to prostate cancer, Carcinoembryonic antigen (CEA) to colorectal cancer, CA125 to ovarian cancer, CA19.9 to pancreatic cancer and CA27.29 to breast cancer.

6 Sep 2017

High levels of suPAR protein shown to be likely cause of kidney damage in children

High levels of a protein known as suPAR, which has been shown to be a marker and likely cause of kidney damage, is as reliably predictive in children as in adults, according to results of a study published online today in JAMA Pediatrics, a clinical publication of the American Medical Association.

5 Sep 2017

Breast Cancer News and Research

Latest Breast Cancer News and Research

Immunotherapy could help some breast cancer patients based on genetic changes in their tumors

MTI awards $25,000 grant to MDI Biological Laboratory scientist for peripheral neuropathy research

Study finds potential preventive for chemotherapy-induced peripheral neuropathy

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

Researchers reveal possible origin of cancer-associated fibroblasts

Study identifies late effects that may interfere with work status of young adult cancer survivors

LORELEI trial: Treatment with alpha specific PI3K inhibitor reduces breast tumor size

Research: Alcohol industry misrepresenting evidence about alcohol-related cancer risk

Eli Lilly to lay off 8.5 percent of employees in bid to cut costs

Alcohol related cancer risks underplayed by industry says new research

Seeing the full picture, real-time analysis of live-cells

New microfluidic device offers insights on cancer metastasis

Myriad Genetics introduces new precision medicine tool to enhance myRisk Hereditary Cancer test

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

High levels of suPAR protein shown to be likely cause of kidney damage in children

New research could reduce recurrence of prostate cancer

Measuring breast density

Increased genomic risk can make small tumors aggressive, study says

Even small tumors can be aggressive in early stage breast cancer patients, study shows

Existing drug may one day protect premenopausal women from infertility after cancer treatments

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Breast Cancer News and Research

Latest Breast Cancer News and Research

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Newsletters you may be interested in